DEC 14, 2016 7:36 AM PST

Could Statins be Repurposed to Prevent Alzheimer

WRITTEN BY: Xuan Pham

A new study finds an association between statin use and decreased Alzheimer risks. The study underscores the connection between healthy body and mind, and suggests that, on some level, we may be able to exert some control over neurodegeneration.

Statins are often prescribed to help lower cholesterol levels, especially for patients at high risk for coronary heart disease. Formally known as HMG-CoA reductase inhibitors, statins work to lower cholesterol by blocking a key enzyme, HMG-CoA reductase, which has a central role in the production of LDL cholesterol.

The study analyzed statin use in a cohort of nearly 400,000 statin users, all 65 years or older. Then, the participants were followed for a period of 4 years to assess their Alzheimer’s status. The team, led by Julie Zissimopoulos at the University of Southern California, found that people who had used more statins were 10 percent less likely to be diagnosed with Alzheimer’s disease.

The startling association varied depending on sex and ethnicity. "We found risk reduction was slightly higher for women compared to men. So for women, the risk reduction and the onset of Alzheimer's was 15%. For men, it was 12%," Zissimopoulos said.

Furthermore, different statins were associated with different Alzheimer risks. Simvastatin (Zocor) was associated with a lower risk for white men and women, Hispanic men and black women. Atorvastatin (Lipitor) was associated with reduced risk for white, black and Hispanic women and Hispanic men. Pravastatin (Pravachol) and rosuvastatin (Crestor) were associated with reduced risk for white women only.

"All of the statins seem to have some risk reduction, although the findings are much more consistent for simvastatin and atorvastatin, meaning they consistently reduce the risk of Alzheimer's disease across men and women and across most race and ethnic groups," said Zissimopoulos.

Some statins, particularly Simvastatin and atorvastatin, are liophillic and are able to cross the blood-brain barrier. The researchers hypothesize this may be why these two statin types showed such consistent findings with reduced Alzheimer risks.

These results may serve to mitigate some disappointment caused by the announcement of Eli Lilly’s Alzheimer drug trial fail last month. However, Zissimopoulos is quick to note that the her study isn’t designed to claim cause-and-effect between statins and Alzheimer’s disease.

"It’s important to know that this is not a study that establishes causality, because it's not an experiment," she said. "It's really important to put this study in the context of where we are in Alzheimer's disease treatment and prevention, and there's still no treatment that exists to delay or prevent Alzheimer's disease."

So, what can patients or proactive individuals do with these results? "If somebody asks, 'Should I be taking a statin to prevent Alzheimer's disease?' I would say, 'Well, there are some data that indicate that, but I would rather have you take your statin if your primary physician says you need it for vascular purposes,' " said Ronald Petersen, director of the Mayo Clinic Alzheimer's Disease Research Center.

Additional source: CNN

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 13, 2021
Cardiology
Can a Ketosis Metabolite Act as a Biomarker for Cardiovascular Diseases?
APR 13, 2021
Can a Ketosis Metabolite Act as a Biomarker for Cardiovascular Diseases?
Quick and reliable diagnostics are the key to controlling many diseases, including cardiovascular disease. Biomarkers ar ...
MAY 21, 2021
Neuroscience
New Method to Predict Treatment Outcomes for Epilepsy 95% Accurate
MAY 21, 2021
New Method to Predict Treatment Outcomes for Epilepsy 95% Accurate
Scientists from the University of Nottingham have found that the way neurons are connected within different brain region ...
JUN 30, 2021
Clinical & Molecular DX
A Deep Learning Tool for Faster, Better Heart Disease Diagnoses
JUN 30, 2021
A Deep Learning Tool for Faster, Better Heart Disease Diagnoses
A new deep learning tool could help slash the time it takes to interpret cardiology scans to diagnose obstructive corona ...
AUG 08, 2021
Cardiology
Strong Links Between PTSD and Heart Disease
AUG 08, 2021
Strong Links Between PTSD and Heart Disease
The link between heart disease and stress is well known, but researchers still have a lot to learn about that associatio ...
AUG 09, 2021
Genetics & Genomics
Middle Eastern Data Fills in Some Knowledge Gaps on Human Genetics
AUG 09, 2021
Middle Eastern Data Fills in Some Knowledge Gaps on Human Genetics
Although the human genome has basically the same genes from one person to the next, there is a huge amount of variation ...
SEP 16, 2021
Drug Discovery & Development
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
SEP 16, 2021
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
According to the Population Reference Bureau, 40 million people in the United States are aged 65 and older. This nu ...
Loading Comments...